Primary EndoCannabinoids

CANNABIRIPSOL (CBR)

Cannabiripsol (CBR) is a recently discovered element and  is thought to be a cannabiglendol compound. Marijuana, aside from its euphoric effect, has several medical advantages, some of which have been validated via study.

Meanwhile, experts have hypothesized on some potential benefits, while others remain a mystery. The gray zone will always exist until there is a permit for the free usage of this plant.


CBR was reportedly discovered in South Africa from a cannabis plant variety. Scientists in South Africa were able to identify and isolate the compound by spectral techniques, even though it appears in low quantities.
CBR formation are yet to be researched. We do, however, know about its chemical and physical characteristics.
We don't know enough about how this compound is formed, except from its chemical properties. Some scientists assume that it is produced just as cannabinols and their sister compounds.
CBR has a canonicalized topological surface area of 69.9A2 and a heavy atom count of 25. Its bond structure has four rotatable bonds, four hydrogen bond acceptors, and three hydrogen donors. It has a property complexity rating of 465 and a mass of 346.5g/mol.


CBR’s working nature
 

There is considerable research being conducted to better understand how CBR interacts to receptors in the human body. CBR is thought to respond differentially to CB1 and CB2 immune system receptors. To promote our health, these receptors bind with cannabinols.
There were no supporting evidence or studies on these tests, but we do know that they are being conducted. Understanding how the CBR chemical works is as important as understanding how the cannabinoids works.
Since we don't know how CBR works, we don't know what therapeutic benefits it has. More research will hopefully reveal what therapeutic benefits this chemical possesses, as well as if it is psychoactive or an anti-agent. There is a need for more clinical trials, testing, and investigations.